CIK 0001404644
- Non-accelerated filer
- Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 980542593
- Phone
- +1 877-237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- 4 Open-market sale Senior Vice President sold 2,400 shares at $12.58 ($30,192)
- 4 Open-market sale Senior Vice President sold 600 shares at $13.00 ($7,800)
- 4 Open-market sale Senior Vice President sold 1,800 shares at $11.98 ($21,564)
- 4 Open-market sale Senior Vice President sold 1,800 shares at $12.22 ($21,996)
- 4 Open-market sale Senior Vice President sold 1,800 shares at $12.02 ($21,636)
- 4 Open-market sale Senior Vice President sold 600 shares at $13.00 ($7,800)
- 4 Open-market sale Senior Vice President sold 1,800 shares at $11.96 ($21,528)
- 4 Open-market sale Senior Vice President sold 2,400 shares at an average $11.96 ($28,716)
- 4 Open-market sale Senior Vice President sold 1,200 shares at $11.36 ($13,632)
- 4 Open-market sale Chief Financial Officer sold 6,497 shares at $11.01 ($71,556)
- 4 Open-market sale Senior Vice President sold 1,800 shares at $11.97 ($21,540)
- 4 Open-market sale Senior Vice President sold 1,800 shares at $11.87 ($21,360)
- 4 Open-market sale Senior Vice President sold 2,400 shares at an average $12.36 ($29,652)
- 4 Open-market sale Senior Vice President sold 2,400 shares at $12.70 ($30,480)
- 4 Open-market sale Senior Vice President sold 3,000 shares at $14.20 ($42,600)
- 4 Open-market sale Senior Vice President sold 600 shares at $14.00 ($8,400)
- 4 Open-market sale Senior Vice President sold 2,400 shares at $13.23 ($31,752)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 424,000 shares at $15.25 ($6,466,000)
Page 7 of 15 · 287 filings